Session Details

[3S20m]Cancer glycans: Introduction of Cancer-associated glycans

Wed. Nov 5, 2025 8:45 AM - 10:45 AM JST
Wed. Nov 5, 2025 11:45 PM - 1:45 AM UTC
Room20(Room 555)
Organizers:Yuki Ohkawa(Department of Glyco-Oncology and Medical Biochemistry, Osaka International Cancer Institute), Satomi Nadanaka(Kobe Pharmaceutical University)

[3S20m-00]Introduction

Yuki Ohkawa (Department of Glyco-Oncology and Medical Biochemistry, Osaka International Cancer Institute)
Comment()

[3S20m-01]Usability and practicality of cancer-associated glycans

Yuki Ohkawa (Department of Glyco-Oncology and Medical Biochemistry, Osaka International Cancer Institute)
キーテクノロジー:CD151のN 型糖鎖解析
Comment()

[3S20m-02]The Role of Chondroitin Sulfate in Defining Cancer Development and Malignant Transformation

Satomi Nadanaka, Hiroshi Kitagawa (Kobe Pharmaceutical University)
キーテクノロジー:糖鎖解析
Comment()

[3S20m-03]Regulation of the tumor microenvironment by EVs expressing cancer-associated gangliosides

Yuhsuke Ohmi, Hiroka Koyanagi, Gong Xiaoyu, Orie Tajima, Koichi Furukawa, Keiko Furukawa (Department of Biomedical Sciences, Graduate School of Life and Health Sciences, Chubu university)
キーテクノロジー:がん関連糖脂質の機能解析技術
Comment()

[3S20m-04]Multifunctional Role of Sialyl-Tn Antigen in Linking Hypoxia and the Regulation of Cancer Microenvironment

Kazuaki Ohtsubo (Dept. of Biomol. Reg. Analytics, Fac. of Life Sci., Kumamoto Univ.)
キーテクノロジー:糖鎖発現制御
Comment()

[3S20m-05]Advanced glycotechnology in cancer: Design for biobetter drugs

Yasuyuki Matsumoto1,2 (1.Harvard Medical School, 2.Beth Israel Deaconess Medical Center)
キーテクノロジー:Glycotechnology
Comment()